Background/Aims: This study aimed to investigate the mechanism by which microRNA-206 (miR-206) affects the proliferation, apoptosis, migration and invasion of osteosarcoma (OS) cells by targeting ANXA2 via the AKT signaling pathway. Methods: A total of 132 OS tissues and 120 osteochondroma tissues were examined in this study. The targeting relationship between miR-206 and ANXA2 was verified with a dual-luciferase reporter assay. The miR-206 expression and ANXA2, AKT, PARP, FASN, Survivin, Bax, Mcl-1 and Bcl-1 mRNA and protein expression in the above two groups were examined by qRT-PCR and western blotting. The cultured OS cells were divided into 6 groups: a blank group, negative control (NC) group, miR-206 mimic group, miR-206 inhibitor group, si-ANXA2 group and miR-206 inhibitor + si-ANXA2 group. Cell cycle and apoptosis were assessed by flow cytometry, cell migration was examined with a wound-healing assay, and cell invasion was assessed with a Transwell assay. markedly, cell proliferation was inhibited, apoptosis was promoted, higher cell growth in G1 phase and decreased growth in S phase was detected, and decreased cell migration and invasion were observed compared with those in the blank group. Conclusion: The current results demonstrate that miR-206 overexpression inhibits OS cell proliferation, migration and invasion and promotes apoptosis through targeting ANXA2 by blocking the AKT signaling pathway.
Introduction
Osteosarcoma (OS) is the most common malignant bone tumor, has a high incidence and mortality in children and adolescents and exhibits high destructive and metastatic potential [1] . However, the precise etiology of OS and a rational treatment approach remain elusive [2] . The commonly used therapeutic strategies include preoperative chemotherapy or radiotherapy, surgical resection of all known disease or metastatic tissues and postoperative management [3] . However, these treatments have failed to promote complete recovery because of chemoresistance, and patient prognosis is often poor; furthermore, secondary occurrence of the disease is high [4] . Fortunately, with the recently expanding body of research, increasing evidence indicates that this disease is a differentiation disease arising from genetic and epigenetic differentiation of mesenchymal stem cells into osteoblasts [5] . It is distinct from the identified role of other chromosome aberrations in OS, such as 6P12 and cMYC, and little is known about the role that microRNAs (miRNAs) may play in curing this malignant cancer [6] .
miRNAs are a class of small, noncoding, single-stranded RNA molecules that are approximately 18-25 nucleotides in length, and they play critical roles in regulating gene expression and in biological processes, such as proliferation, differentiation and apoptosis of tumor cells [7] . In recent years, miRNA molecules have been found to be an important part of cancer diagnosis and prognosis, and they are potential biomarkers and therapeutic targets for drug discovery [8] . miR-206, a member of the tumor suppressive miRNA family, has been found to be down-regulated in human malignancies relevant to tumor progression, including human OS [9] . Annexin A2 (ANXA2), a calcium-and phospholipid-dependent protein, is distributed throughout the cell surface and could be a biomarker for certain tumors because ANXA2 deregulation and upregulation are associated with cancers from initiation to metastasis [10] . AKT/Protein kinase B (AKT/PKB) is a family that includes three homologous members and plays a remarkable role in cell survival and protein synthesis; family members are classified as serine/threonine protein kinases [11] . A previous study has suggested the possibility that miRNAs, such as miR-93, target certain genes and take part in regulating the AKT/PKB signaling pathway [12] . In the present study, we explore and elaborate on the role of miR-206 in regulating the proliferation and invasion of OS cells by targeting ANXA2 via the AKT signaling pathway.
Materials and Methods

Study Subjects
Altogether, 132 OS tumor tissue samples derived from 132 OS patients were collected from September 2011 to September 2016. Among the 132 OS patients, 74 were males and 58 were females, with ages ranging from 9 to 53 years (mean age: 27.21 ± 9.34 years old). Overall, 120 amputees were selected to obtain osteochondroma (a benign bone lesion) tumor tissue samples; they included 69 males and 51 females, whose ages ranged from 8-58 and whose mean age was 27.93 ± 10.87. Both groups met the following inclusion criteria: traditional OS was confirmed by clinical, imaging and case diagnosis; tumors were located only in limbs, with no metastasis before diagnosis; patients underwent standard diagnostic procedures; and none of the patients were treated with radiotherapy or chemotherapy. The following exclusion criteria were noted: secondary symptoms; diagnostic procedures not complied with; other therioma history on record; and metastasis occurring before diagnosis. Each sample was preserved at -80°C. This study was conducted in accordance with the Declaration of Helsinki and received approval from the Ethical Committee of Yunnan Cancer Hospital & The Affiliated Hospital of Kunming Medical University & Yunnan Cancer Center. The above samples were collected from patients who provided informed consent.
Hematoxylin and eosin (HE) staining
All samples in the two groups were fixed with 10% neutral buffered formalin for 16-18 h (5-7 days of decalcification was necessary for bone tissue), dehydrated by gradient alcohol, hyalinized in xylene, dipped in wax, embedded in paraffin and subsequently continuously sectioned at a thickness of 5 μm. Next, the sections were spread out at 45°C, roasted at 60°C for 1 h, and dewaxed by xylene. Subsequently, gradient HE staining (Beijing Solarbio Science & Technology Co., Ltd., Beijing, China) was performed after hydration. After secondary dehydration and vitrification and sealing with neutral balsam, the pathological changes in these sections were observed under an optical microscope (CX31-LV320, Olympus Optical Co., Beijing, China).
Immunocytochemistry
OS and osteochondroma tissues were embedded in paraffin, and 3-to 4-μm sections were prepared. The sections were placed in 3% H 2 O 2 before gradient dewaxing and hydration for 20 min at room temperature to block endogenous peroxidase. Antigen repair was underway after incubation in an 80% power microwave for 5 min. Rabbit anti-mouse Annexin A2 (ANXA2) (ab178677, Abcam Inc., Cambridge, MA, USA) monoclonal antibody (1:1000) was incubated with sections at 4°C overnight, and biotinylated goat anti-mouse IgG secondary antibody (1:1000, ab6789, Abcam Inc., Cambridge, MA, USA) was added and incubated with sections at 37°C for 30 min. Then, secondary staining with hematoxylin (No: Co105, Beyotime Biotechnology Co., Shanghai, China) was performed for 30 s, and the tissues were developed with diaminobenzidine (DAB) (No: P0202, Beyotime Biotechnology Co., Shanghai, China). The sections were dehydrated with hydrochloric acid and alcohol until vitrification, sealed with balsam, and subsequently observed and photographed under a microscope (CX31-LV320, Olympus Optical Co., Beijing, China). Two positive and negative results were presented: brownish yellow in the cytoplasm and cytomembrane indicated positive staining, and otherwise indicated negative staining. The positive protein expression rate was calculated as follows: five 200 × fields were randomly selected for detection, and the ratio of the positive cells was calculated. The experiment was performed 3 times.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Approximately 100 mg of frozen tissue was placed into a glass homogenizer to obtain total homogenate. A Trizol TM kit (No: 16096020, Thermo Fisher Scientific Inc., Waltham, MA, USA) was adopted to obtain total RNA using a twostep method. Primers were designed by Premier 5 and Oligo 6 and are shown in Table 1 ; Takara Co. performed the synthesis. Subsequently, 10 μL of RNA was diluted 1/20 times in RNase-free ultrapure water to test the concentration and purity by recording the absorption values at 260 and 280 nm via ultraviolet (UV) spectrophotometry. The total RNA value was 1.25/optical density (OD) 260 (μL). Altogether, 5 μL of the kit reagent, 5 μL of total RNA and 10 μL of RNase-free H 2 O were added to an Eppendorf tube, centrifugally mixed and reacted in qPCR. The following reaction conditions were used: 37°C for 15 min and 85°C for 5 s; the reaction was stopped at 4°C; and cDNA was obtained and preserved at -20°C. An ABI 7500 quantitative PCR 
Western blotting
The obtained OS and osteochondroma tumor tissues were added to liquid nitrogen and ground into a thin powder, which was subsequently centrifuged at 13000 r/min and 4°C for 15 min after the addition of lysate (No: C0481, Sigma-Aldrich Chemical Co., St Louis MO, USA), and the supernatant was stored for later experiments. Next, the protein concentration in the samples was assessed with a bicinchoninic acid (BCA) assay and adjusted to be consistent with the loading quantity by removing ionized water. Then, 10% separation and stacking gels for sodium dodecyl sulfate (SDS) electrophoresis were generated. After mixing the sample and loading buffer, the mixture was boiled at 100°C for 5 min, and the equivalent sample amounts were electrophoretically separated using pipettes after an ice-bath and centrifugation. Subsequently, the protein on the gel was transferred onto a nitrocellulose membrane, followed by blocking with 5% skimmed milk powder at 4°C overnight. , LTD., Hubei, China), the sample was reacted at room temperature for 1 h, followed by 3 washes with PBS (5 min each time). The membrane was immersed in electrochemiluminescence (ECL) reaction solution (Pierce Manufacturing Inc. Appleton, WI, USA) for 1 min at room temperature and was then covered with preservative film to remove the liquid. The results were acquired via X-ray detection. Taking GAPDH as an internal reference, the ratio of the gray values between the target and reference bands was considered the comparative expression of proteins. The experiment was repeated 3 times (appropriate for the cell experiment).
Verification of a targeting relationship between miR-206 and ANXA2
Target gene analysis was conducted to analyze miR-206, and its targeting relationship with ANXA2 was predicted using the bioinformatics prediction website microRNA.org. The artificial ANXA-3'UTR gene segment was introduced into a pMIR-reporter (Promega Corporation, Madison, WI, USA) via the endonuclease cleavage sites SalI and BglII. Complementary sequence mutant sites of the seed sequence were designed at ANXA2 wild type, and the target segment was inserted into the pMIR-reporter plasmid with T4 DNA ligase via restriction endonucleases. The PRL-TK carrier expressing Renilla luciferase (Takara Biotechnology Ltd., Dalian, China) was taken as the internal reference to regulate the cell quantity and differences in transfection efficiency. miR-206 mimic and negative reference were co-transfected into OS cells with the luciferase reporter, and after 48 h, the cells were collected and disrupted. The Dual-Luciferase Reporter Assay System (Promega Corporation, Madison, WI, USA) was used to test the activity of luciferase. The experiment was repeated 3 times.
Cell transfection
The human OS cell line MG-63 (Cell Resource Center, IBMS, CAMS/PUMC, Beijing, China) was cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco Co., Grand Island, NY, USA) containing 10% fetal bovine serum, seeded onto a 6-well culture plate at a density of 1 × 10 5 cells in each well and then cultivated in an incubator with a saturated humidity of 5% CO 2 at 37°C. At 80 -90% confluence, cells were passaged in DMEM containing 10% fetal bovine serum.
Extracted human OS cells in logarithmic phase were transfected and assigned to 6 groups: a blank group (no transfection), negative control group (transfected with NC sequence in transfection kit), miR-206 mimic group (transfected with miR-206 mimic sequence), miR-206 inhibitor group (transfected with miR-206 inhibiting sequence), si-ANXA2 group (transfected with siRNA sequence of ANXA2) and miR-206 inhibitor + si-ANXA2 group (co-transfected with miR-206 inhibitor and siRNA sequence of ANXA2). All transfected sequences (Table 2) were synthesized by Shanghai Sangon Biotech Co. Ltd. (Shanghai, China). The following procedures were conducted for cell transfection: cell passage was addressed before the day of transfection, and cells were inoculated onto a 6-well plate with 1 × 10 5 cells in each well until 70-80% confluence was reached. Cell transfection was performed with a Lipofectamine ® 2000 kit (11668019, Invitrogen Inc., Carlsbad, CA, USA) as indicated. Altogether, 250 μL of DMEM containing no serum was used to dilute 100 pmol of the above groups, except for the blank group (the final concentration was 50 nM); the same medium was used to dilute 5 μL of Lipofectamine ® 2000, followed by incubation for 5 min at room temperature after mixing well. After complete mixture of the above samples, a 20-min incubation at room temperature was conducted prior to addition of the mixed solutions to the culture wells. Following the transfection, the cells were cultured in the incubator with 5% CO 2 at 37°C for 6-8 h. Finally, the complete culture medium was cultured for another 24-48 h for a later experiment.
Cell counting kit-8 (CCK-8) assay
Transfected human OS cells were seeded onto a 96-well plate, and 100 μL of culture medium was added. The density of the cells was adjusted to 2 × 10 3 cells/mL. The plate was incubated at 37°C for culture, and cell activity was recorded after 24, 48 and 72 h. After adding 10 μL of CCK-8 kit reagent (C0037, Beyotime Biotechnology Co., Shanghai, China) and incubation at 37°C for 2 h, the OD value was recorded at 450 nm/630 nm using a microplate reader (Multiskan FC, Thermo Fisher Scientific Inc., NY, USA). Three parallel wells were set in each group, and the mean value was calculated. A cell activity graph was drawn, with the x-axis referring to time and the y-axis representing the OD value. The experiment was repeated 3 times.
Flow cytometry (FCM) assay
After 48 h of transfection, the culture medium was removed, and the cells were washed once with PBS solution. After digestion with 0.25% trypsin solution, the cells were observed under a microscope until they became round. Subsequently, serum culture medium was added to terminate digestion. A cell suspension was produced after isolating cells from the cytoderm and was centrifuged at 1000 r/min for 5 min, with the supernatant subsequently removed. After two washes with PBS, the cells were fixed with 70% pre-chilled ethanol for 30 min and collected by centrifugation. After washing with PBS, the cells were stained with 1% propidium iodide (PI) containing RNA enzyme for 30 min. Then, the PI was rinsed off twice via PBS washes. The volume was adjusted to 1 mL with PBS. Finally, the cell cycle distribution was assessed by putting samples into a BD-Aria FACSCalibur flow cytometer (FACSCalibur; Beckman Coulter, Inc., Chaska, MN, USA) (there were 3 samples in each group, and the experiments were performed 3 times).
At 48 h after transfection, the cells were digested by pancreatin with no ethylenediaminetetraacetic acid (EDTA), collected into flow tubes and centrifuged; then, the supernatant was abandoned. After 3 washes with chilled PBS, the cells were centrifuged, and the supernatant was abandoned again. Following the instructions of the Annexin-V-fluorescein isothiocyanate (Annexin-V-FITC) cell apoptosis kit (C1065, Beyotime Biotechnology Co., Shanghai, China), Annexin-V-FITC, PI and hydroxyethyl piperazine ethanesulfonic acid (HEPES) buffer solutions were used to prepare the Annexin-V-FITC/PI staining solution at a ratio of 1: 2: 50. Then, 1 × 10 6 cells were resuspended in every 100 µL of staining solution. After being well mixed, the cells were incubated for 15 min at room temperature and later mixed again following the 
addition of 1 mL of HEPES. A 488-nm wavelength was used for excitation, with a 525 and 620 nm bandpass filter, to detect cell apoptosis by measuring FITC and PI fluorescence.
Wound-healing assay
Transfected cells were seeded onto a 6-well plate with 5 × 10 5 cells per well. When the cell confluence reached approximately 90%, a thin wound was created along the center of each well with a sterile pipette tip. After the floating cells were washed out with PBS, the cells were cultured in serum-free medium for 0.5-1 h until cell recovery occurred. Taking the precise moment of cell recovery as 0 h, images were acquired at 0 and 48 h. Finally, the cell migration distance was examined using Image-Pro Plus Analysis software (Media Cybernetics, Inc., Rockville, MD, USA). Three experiments were required to obtain an average value. 5 /mL was seeded onto the upper chamber, with serum-free medium in the bottom chamber. Subsequently, 10% FBS medium was added to the bottom chamber for the 24-h invasion assay. Cell invasion ability was measured as the number of cells passing through the chamber. The mean value was obtained via 3 experiments.
Transwell assay
Serum-free culture medium (1:3) was used to diluted Matrigel (No: 356234, Becton, Dickinson and Company, NJ, USA), which was incubated at 4°C overnight. Matrigel was added to the upper surface of the Transwell chamber, with 50 μL in each well, and equilibrated for 30 min in the incubator. A cell suspension of 1 × 10
Statistical analysis
All data analyses were conducted using SPSS 21.0 (IBM Corp., Armonk, NY, USA). The results are expressed as the means ± standard deviation. Differences between two groups were compared by LSD-t, and differences between multiple groups were examined by variance analysis. Pearson correlation analysis was used to determine the correlation between ANXA2 mRNA expression and miR-206 expression in OS. P < 0.05 was considered statistically significant.
Results
Pathological changes in OS and osteochondroma tissues
Three layers were observed in osteochondroma tumor tissues, with fibrous tissue detected in the outer layer, cartilaginous tissue in the middle layer and bone formation in the internal layer, which indicated that the cells had been fully differentiated, with no variation. In contrast, OS cells in tissues were concentrated and presented marked nuclear atypia, and they were increased in both number and size, with more hyperchromatic nuclear grains resulting from increased nuclear chromatin. Notably, nuclear division was observed. A neoplastic bone and labyrinthine osteoid matrix appeared among atypical spindle cells with infiltrative growth (invading the surrounding bone tissues) (Fig. 1) .
Immunohistochemical results of ANXA2 analysis in OS and osteochondroma tissues
The results suggested that ANXA2 was highly expressed in the cell membrane. The cell cytoplasm presented a brownish yellow color, and ANXA2 was somewhat distributed in the nucleus. Obviously more intense staining was present in OS tissues than in osteochondroma tissues, and the protein expression of ANXA2 in OS tissues (51.3%) was dramatically higher than that in osteochondroma tissue (17.8%) (P < 0.05) (Fig. 2) . 
miR-206 expression and mRNA and protein expression of ANXA2, AKT, PARP, FASN, Survivin, Mcl-1 and Bcl-2 in OS and osteochondroma tissues
As detected by qRT-PCR and western blotting (Fig. 3) , ANXA2, AKT, PARP, FASN, Survivin, Mcl-1 and Bcl-2 were expressed at higher levels in OS tissues than in osteochondroma tissues; however, the mRNA and protein expression of Bax and miR-206 was significantly decreased (all P < 0.05). ANXA2 mRNA expression was strongly negatively correlated with miR-206 expression in OS (P < 0.05).
ANXA2 is the target gene of miR-206
The target site of miR-206 on ANXA2 was confirmed via an online prediction website. Fig. 4A shows the mRNA sequence of ANXA2 and the 3'-UTR sequence combined with miR-206. To verify whether miR-206 binding to the predicted site leads to changes in luciferase activity, wild-type and mutant sequences lacking the miR-206 combination sites in the ANXA2 3'-UTR were inserted into a reporter plasmid. The miR-206 mimic and WT-miR-206/ANXA2 or MUT-miR-206/ANXA2 recombinant plasmids were co-transfected into OS cells, and the results showed that MUT-miR-206/ANXA2 had no significant effects on the luciferase activity, but the luciferase activity was markedly decreased in the WT-miR-206/ANXA2 group (P < 0.05) (Fig. 4B) .
Comparison of miR-206, ANXA2, AKT, PARP, FASN, Survivin, Bax, Mcl-1 and Bcl-2 expression among six groups
Between the blank group and the NC group, the expression of miR-206, ANXA2, AKT, PARP, FASN, Survivin, Bax, Mcl-1 and Bcl-2 presented no significant difference (all P > 0.05). Compared with the blank group, miR-206 was more highly expressed in the miR-206 mimic group (P < 0.05), and miR-206 showed no statistically significant expression difference in the si-ANXA2 group (P > 0.05). However, the mRNA and protein expression of ANXA2, AKT, PAPP, FASN, Survivin, Mcl-1 and Bcl-2 was reduced in the miR-206 mimic 
and si-ANXA2 groups, but Bax expression increased (all P < 0.05). Taking the blank group as the control, reduced miR-206 expression was detected in the miR-206 inhibitor group, whereas the mRNA and protein expression of ANXA2, AKT, PAPP, FASN, Survivin, Mcl-1 and Bcl-2 was higher and Bax decreased (all P < 0.05). In the miR-206 inhibitor + si-ANXA2 group, the expression level of miR-206 was tested (P < 0.05), and the expression of miR-206, ANXA2, AKT, PAPP, FASN, Survivin, Mcl-1 and Bcl-2 at the mRNA and protein levels showed no statistically significant differences (all P > 0.05) (Fig. 5) .
miR-206 overexpression inhibits OS cell proliferation
As shown in Fig. 6 , no significant difference in cell growth was observed at each time point among the blank group, the NC group and the miR-206 inhibitor + si-ANXA2 group (P >0.05). Compared with the blank group, cell proliferation was inhibited in the miR-206 mimic and si-ANXA2 groups at all time points and was promoted in the miR-206 inhibitor group at all time points (all P < 0.05).
Comparisons of cell cycle distribution and apoptosis among the six groups after transfection
In the G1 and S phases, there was no notable difference in cell distribution among the blank group, the NC group and the miR-206 inhibitor + si-ANXA2 group (P > 0.05). Between the miR-206 mimic group and the si-ANXA2 group, the cell distribution was also similar in the G1 and S phases (P > 0.05). Compared with the blank group, the miR-206 mimic group and the si-ANXA2 group had an increased cell number in G1 phase and a decreased cell number in S phase (P < 0.05), whereas the miR-206 inhibitor group had a decreased cell number in G1 phase but an increased number in S phase (P < 0.05). No significant difference was observed in the cell apoptosis rate among the blank group, the NC group and the miR-206 inhibitor + si-ANXA2 group (P >0.05). There was also no significant difference in the cell apoptosis rate between the miR-206 mimic and the si-ANXA2 group (P > 0.05). Compared with the blank group, an increased cell apoptosis rate was observed in the miR-206 mimic group; however, the apoptosis rate in the miR-206 inhibitor group was reduced (all P < 0.05) (Fig. 7) .
miR-206 overexpression decreased migration intensity and invasive cell number
No notable differences in cell migration were detected among the blank group, the NC group and the miR-206 inhibitor + si-ANXA2 group or between the miR-206 mimic group and the si-ANXA2 group (P > 0.05). Compared with the blank group, the miR-206 mimic and si-ANXA2 groups had decreased migration intensity, but the miR-206 inhibitor group had increased migration intensity (all P < 0.05) (Fig. 8A) .
The number of cells that invaded from the upper Transwell chamber to the lower chamber was similar among the blank group, the NC group and the miR-206 inhibitor + si-ANXA2 group, which resembled the comparison between the miR-206 group and the si-ANXA2 group (all P >0.05). Compared with the blank group, the number of cells invading from the upper chamber to the bottom chamber decreased largely in the miR-206 mimic group and the si-ANXA2 group but increased in the miR-206 inhibitor group (all P < 0.05) (Fig. 8B and C) .
Discussion
A recent study showed that OS is the primary cause of cancer death in the second decade of life [1] . The introduction of traditional chemotherapy for OS, including key anticancer drugs, was popular 3 decades ago, but its further progress seems to have stagnated [14] . Emerging evidence has shown that miRNAs and the target genes that they regulate may offer new therapeutic targets against OS or be potential biomarkers [15] . The present study focused on investigating the effects of miR-206 on regulating the proliferation and invasion of OS cells by targeting ANXA2 via the AKT signaling pathway. The results showed that miR-206 overexpression inhibited cell proliferation, migration and invasion and promoted apoptosis by inhibiting ANXA2 via the AKT signaling pathway. Compared with osteochondroma tissues, the mRNA and protein expression of ANXA2, AKT, PARP, FASN, Survivin, Mcl-1, and Bcl-2 was strikingly increased, but that of Bax and miR-206 was decreased in OS tissues. Aberrant miR-206 expression has been predicted to be significant in the progression of OS, the most well-known malignant tumor, and down-regulation of miR-206 expression was recently shown in OS patients to occur more frequently and lead to higher mortality rates [16] . A previous study demonstrated that ANAX2, a phospholipid-binging protein, is essential in accelerating cancer metastasis, is highly expressed in many tumor types and plays positive or negative roles in cell proliferation, migration and other cellular functions [17] . It also has been widely reported that the AKT signaling pathway is oncogenic in humans, and hyper activation of AKT signaling in OS has been observed [18] . In a previous study, evodiamine, a type of traditional Chinese medicine, was effective against OS by down-regulating Bcl-2 and Survivin expression and upregulating Bax expression [19] . Furthermore, FASN is considered a potential target for treating OS, based on its low expression demonstrated in a previous study [20] . The above evidence prompted the design of a deeper-reaching experiment to confirm some relationships and find feasible treatments.
In this study, we found markedly decreased mRNA and protein expression of ANXA2, AKT, PARP, FASN, Survivin, Mcl-1 and Bcl-2 and increased expression of Bax in the miR-206 mimic and the si-ANXA2 groups compared with those in the blank group. In addition, ANXA2 was identified as the direct target gene of miR-206. A previous study also indicated that the ANXA2 gene is directly targeted by miR-206 in pancreatic adenocarcinoma cells, from which the inverse correlation between ANXA2 and miR-206 expression was evidenced [21] . It has been demonstrated that some miRNAs down-regulate AKT [22] ; in particular, upregulation of miR-206 via transfection with a mimic significantly reduced AKT expression, indicating that miR-206 is an inhibitor of the AKT signaling pathway, consistent with our findings [23] . Mcl-1, a member of the Bcl-2 family that regulates cell processes, such as apoptosis, functions similarly to the Bcl-2 protein [24] . In addition, low expression of ANXA2 induced by ANXA2 siRNA reduced the expression of Bcl-2 but elevated Bax expression in some cancer cells, such as gastric cancer cells, as noted in a previous study, which also noted inhibition of AKT pathway activation [25] . These findings may help build a potential approach for novel treatments for this disease by regulating miR-206 and its target genes.
We also observed that OS cell proliferation, migration and invasion were all weakened and that cell apoptosis was accelerated in the miR-206 mimic group and the si-ANXA2 group, suggesting that silencing miR-206 and ANXA2 was a defense against OS progression. A previous study found that miR-206 overexpression was a restrictive factor for skeletal muscle satellite cell proliferation and for cell invasion of pancreatic adenocarcinoma cell lines [21, 26] . Wang, et al. also revealed that miR-206 overexpression promoted neural cell apoptosis by regulating Otx2, one of its target genes [27] . Furthermore, cell migration is a crucial step in cancer metastasis, and a previous study revealed that upregulation of miR-206 in lung adenocarcinoma cells inhibits cell migration [28] . In line with our results, another study also demonstrated that miR-206 might play a key role in the pathogenesis and development of OS and may provide a potential target for gene therapy [9] . As shown here, miR-206 inversely regulated ANXA2, and the correlation between si-ANXA2 treatment and cell functions may consistently increase. These findings shed light on the role of increased miR-206 expression in malignant progression of OS.
Collectively, our study showed that miR-206 overexpression blocks AKT signaling by down-regulating ANXA2, thereby inhibiting cell proliferation and invasion. This finding is a significant stride toward developing a novel therapy for OS. However, a more comprehensive study is urgently needed to determine the complexity of the genetic family and to fully explore its relationships. 
